These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 16858126

  • 1. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
    Fetih G, Habib F, Katsumi H, Okada N, Fujita T, Attia M, Yamamoto A.
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
    [Abstract] [Full Text] [Related]

  • 2. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
    Fetih G, Lindberg S, Itoh K, Okada N, Fujita T, Habib F, Artersson P, Attia M, Yamamoto A.
    Int J Pharm; 2005 Apr 11; 293(1-2):127-35. PubMed ID: 15778050
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.
    Fetih G, Habib F, Okada N, Fujita T, Attia M, Yamamoto A.
    J Control Release; 2005 Sep 02; 106(3):287-97. PubMed ID: 15982776
    [Abstract] [Full Text] [Related]

  • 4. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
    Yamamoto A, Tatsumi H, Maruyama M, Uchiyama T, Okada N, Fujita T.
    J Pharmacol Exp Ther; 2001 Jan 02; 296(1):84-90. PubMed ID: 11123366
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the influence of nitric oxide donors on intestinal absorption of macromolecules.
    Takahashi K, Numata N, Kinoshita N, Utoguchi N, Mayumi T, Mizuno N.
    Int J Pharm; 2004 Nov 22; 286(1-2):89-97. PubMed ID: 15501005
    [Abstract] [Full Text] [Related]

  • 6. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T, Sugiyama T, Quan YS, Kotani A, Okada N, Fujita T, Muranishi S, Yamamoto A.
    J Pharm Pharmacol; 1999 Nov 22; 51(11):1241-50. PubMed ID: 10632081
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Improvement of intestinal absorption of poorly absorbable drugs by polyamidoamine (PAMAM) dendrimers as novel absorption enhancers].
    Yamamoto A.
    Yakugaku Zasshi; 2010 Sep 22; 130(9):1123-7. PubMed ID: 20823669
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
    Sugiyama T, Yamamoto A, Kawabe Y, Uchiyama T, Quan YS, Muranishi S.
    Biol Pharm Bull; 1997 Jul 22; 20(7):812-4. PubMed ID: 9255426
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
    Uchiyama T, Yamamoto A, Hatano H, Fujita T, Muranishi S.
    Biol Pharm Bull; 1996 Dec 22; 19(12):1618-21. PubMed ID: 8996651
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: utilization of polyamines and bile acids.
    Miyake M, Minami T, Hirota M, Toguchi H, Odomi M, Ogawara K, Higaki K, Kimura T.
    J Control Release; 2006 Mar 10; 111(1-2):27-34. PubMed ID: 16410031
    [Abstract] [Full Text] [Related]

  • 20. Effect of permeability enhancers on paracellular permeability of acyclovir.
    Ates M, Kaynak MS, Sahin S.
    J Pharm Pharmacol; 2016 Jun 10; 68(6):781-90. PubMed ID: 27061718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.